The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers

NCT05200728 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke
Cerebral Edema

Interventions

DRUG: SIM1910-09
DRUG: Placebo

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.